Skip to main content
Premium Trial:

Request an Annual Quote

Lion Biosciences, IBM Offer Hosted Services for Drug Developers

NEW YORK, Oct. 29-Lion Biosciences and IBM will jointly offer hosted computing services over the Internet to drug development companies, the two firms announced today.


The Lion applications and content package, including SRS and Lion DiscoveryCenter, will be paired with IBM software and hardware. IBM will manage the sales and co-direct the marketing for the service.


Beginning in January, the service will be offered by subscription through IBM's e-business mechanism in the United States, Canada, Europe and regions of Asia.


The financial specifics and subscription prices of this joint offering were not revealed.


For more information, see the press release.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.